Mydecine Innovations Group ($MYCO) is a next-generation biotechnology company that is no stranger to headlines. From their inception in 2020, they have made quite a splash. Between their successful development of novel psychedelic compounds, their partnerships with major research institutions, and the acquisition of the successful technology platform Mindleap, Mydecine has shown great potential over…